Compare CDLX & LFVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CDLX | LFVN |
|---|---|---|
| Founded | 2008 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.5M | 145.2M |
| IPO Year | 2018 | N/A |
| Metric | CDLX | LFVN |
|---|---|---|
| Price | $1.04 | $6.18 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $2.25 | ★ $30.50 |
| AVG Volume (30 Days) | ★ 750.8K | 143.3K |
| Earning Date | 11-05-2025 | 02-04-2026 |
| Dividend Yield | N/A | ★ 2.83% |
| EPS Growth | N/A | ★ 143.91 |
| EPS | N/A | ★ 0.78 |
| Revenue | ★ $251,175,000.00 | $228,877,000.00 |
| Revenue This Year | N/A | $1.54 |
| Revenue Next Year | N/A | $7.00 |
| P/E Ratio | ★ N/A | $8.17 |
| Revenue Growth | N/A | ★ 16.77 |
| 52 Week Low | $0.85 | $5.98 |
| 52 Week High | $4.05 | $27.38 |
| Indicator | CDLX | LFVN |
|---|---|---|
| Relative Strength Index (RSI) | 38.77 | 35.84 |
| Support Level | $0.95 | $6.21 |
| Resistance Level | $1.23 | $6.71 |
| Average True Range (ATR) | 0.11 | 0.34 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 27.42 | 39.03 |
Cardlytics Inc operates an advertising platform within financial institutions' digital channels, which include online, mobile, email, and various real-time notifications. The company operates through segments namely, Cardlytics platform in the U.S. and U.K. and the Bridg platform. The Cardlytics platform segment which generates key revenue, operates a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. The Bridg platform generates revenue through the sale of subscriptions to the cloud-based customer-data platform and the delivery of professional services like implementation, onboarding, and technical support. The company receives maximum revenue from the United States.
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.